{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T19:31:22Z","timestamp":1786735882265,"version":"build-2736575974"},"reference-count":7,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Trichol"],"published-print":{"date-parts":[[2019]]},"DOI":"10.4103\/ijt.ijt_57_19","type":"journal-article","created":{"date-parts":[[2019,10,16]],"date-time":"2019-10-16T08:47:28Z","timestamp":1571215648000},"page":"219","source":"Crossref","is-referenced-by-count":14,"title":["Alopecia areata treated with oral azathioprine: A case series"],"prefix":"10.4103","volume":"11","author":[{"given":"Vikrant","family":"Saoji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep","family":"Kulkarni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhushan","family":"Madke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0974-7753.269343-1","first-page":"405","volume-title":"Epidemiology and genetics of alopecia areata","author":"McDonagh","year":"2002","journal-title":"Clin Exp Dermatol"},{"key":"key-10.4103\/0974-7753.269343-2","first-page":"750","volume-title":"Increased dosing requirements for 6-mercaptopurine and azathioprine in inflammatory bowel disease patients six years and younger","author":"Grossman","year":"2008","journal-title":"Inflamm Bowel Dis"},{"key":"key-10.4103\/0974-7753.269343-3","first-page":"108","volume-title":"The adverse effect profile of oral azathioprine in pediatric atopic dermatitis, and recommendations for monitoring","author":"Fuggle","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/0974-7753.269343-4","first-page":"1188","volume-title":"Could azathioprine be considered as a therapeutic alternative in the treatment of alopecia areata.A pilot study?","author":"Farshi","year":"2010","journal-title":"Int J Dermatol"},{"key":"key-10.4103\/0974-7753.269343-5","first-page":"1007","volume-title":"Treatment of recalcitrant adult alopecia areata universalis with oral azathioprine","author":"Va\u00f1\u00f3-Galv\u00e1n","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/0974-7753.269343-6","first-page":"387","volume-title":"Clinical pharmacogenetics implementation consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing","author":"Relling","year":"2011","journal-title":"Clin Pharmacol Ther"},{"key":"key-10.4103\/0974-7753.269343-7","first-page":"1043","volume-title":"Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition","author":"Xing","year":"2014","journal-title":"Nat Med"}],"container-title":["International Journal of Trichology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T18:34:38Z","timestamp":1786732478000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijt.ijt_57_19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":7,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019]]}},"alternative-id":["269343"],"URL":"https:\/\/doi.org\/10.4103\/ijt.ijt_57_19","relation":{},"ISSN":["0974-7753"],"issn-type":[{"value":"0974-7753","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]}}}